Single-arm, Multi-center Study to Evaluate the Safety and Feasibility of Bilateral Epithelium-on Corneal Collagen Cross-linking With Epioxa™ HD/Epioxa™ and UV-A Irradiation Using the O2n™ System and Supplemental Oxygen Using the Boost Goggles® in Subjects With Keratoconus
Status: Recruiting
Location: See location...
Intervention Type: Device, Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
Clinical trial to evaluate the safety and feasibility of corneal cross-linking in both eyes on the same day in subjects with keratoconus.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 13
Healthy Volunteers: f
View:
• Provide written informed consent
• Willing and able to comply with study instructions and follow-up visits
• Diagnosis of keratoconus in each eye
Locations
United States
Ohio
Glaukos Investigative Site
RECRUITING
Westerville
Contact Information
Primary
Study Director
ClinicalResearch@glaukos.com
949-739-8749
Time Frame
Start Date: 2026-05-11
Estimated Completion Date: 2027-09
Participants
Target number of participants: 15
Treatments
Experimental: Epioxa™ HD/Epioxa™ and UV-A Irradiation
Epioxa™ HD/Epioxa™ and UV-A Irradiation using the O2n™ System and Supplemental Oxygen using the Boost Goggles®
Related Therapeutic Areas
Sponsors
Leads: Glaukos Corporation